The Institute aims to advance anti-ageing science and accelerate the development and commercialisation of innovative nutraceutical products to promote healthy longevity
SIRIO Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) – announces the launch of the Sirio Institute for Anti-Ageing (SIA) at the 2025 Boao Health Food Science Conference and Expo. The Institute aims to advance anti-ageing science and accelerate the development and commercialisation of innovative nutraceutical products to promote healthy longevity. By leveraging cutting-edge research and development capabilities, the SIA will provide customers with the knowledge, resources, and support they need to bring truly groundbreaking anti-ageing solutions to the market and gain a competitive edge in the rapidly growing anti-ageing industry.
With the growing global demand for anti-ageing solutions, the SIA will explore the biological mechanisms of ageing and how they can be modulated. Research at the Institute will focus on four core areas: cellular health, probiotics and gut health, muscle health, and reproductive system health. The Institute will be guided by a global scientific advisory board composed of outstanding experts in the field.
Dr Yu-Xuan Lyu, Research Assistant Professor at the Institute of Advanced Biotechnology and the School of Medicine at the Southern University of Science and Technology (SUSTech), will head the newly established institute and assemble the Scientific Advisory Board. The core research at the Institute will target the enhancement of cellular health, the role of probiotics in reducing the ageing process, and the development of novel nutraceutical formulations addressing muscle loss and ovary functional decline during ageing.
